The Top 100 Drugs
Clinical Pharmacology and Practical Prescribing
- 3rd Edition - December 13, 2022
- Authors: Andrew W. Hitchings, Dagan Lonsdale, Daniel Burrage, Emma Baker
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 8 3 4 4 5 - 2
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 3 4 4 8 - 3
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 3 4 4 6 - 9
Now in its third edition, this small and accessible guide contains essential information for the safe prescribing of the most commonly used drugs in the NHS.The Top 100 Drugs com… Read more
Purchase options
Now in its third edition, this small and accessible guide contains essential information for the safe prescribing of the most commonly used drugs in the NHS.
The Top 100 Drugs combines the best elements of a students' textbook with those of a prescribers' manual. It gives equal weight to essential information on the science of pharmacology as well as the real-world practicalities of prescribing, all in an accessible and clear format.
Written by leaders in the field of clinical pharmacology, this popular book has been fully revised and updated to include the drugs used today, including monoclonal antibodies and antiviral drugs for COVID-19. With common indications, mechanism of action, adverse effects, important interactions and a clinical tip for each drug as well as questions to test knowledge, this book is key to helping students understand everything they need to know about the drugs they are likely to use in practice.
- Compact and easy to follow – can be carried around on the wards
- Logically ordered – offers multiple ways to find the drug you are looking for
- A Clinical Tip for each drug, drawn from the authors’ experience
- 100 self-assessment questions to encourage integration and revision of knowledge and understanding
Medical students, junior doctors
List of abbreviations
Introduction
The top 100 drugs listed by system
The top 100 drugs listed by indication
The top 100 drugs (alphabetical listing)
5α-reductase inhibitors
α-blockers
Acetylcholinesterase inhibitors
Acetylcysteine (N-acetylcysteine)
Activated charcoal
Adenosine
Adrenaline (epinephrine)
Aldosterone antagonists
Alginates and antacids
Allopurinol
Aminoglycosides
Aminosalicylates
Amiodarone
Angiotensin-converting enzyme (ACE) inhibitors
Angiotensin receptor blockers
Antidepressants, selective serotonin reuptake inhibitors
Antidepressants, tricyclics and related drugs
Antidepressants, venlafaxine and mirtazapine
Antiemetics, dopamine D2-receptor antagonists
Antiemetics, histamine H1-receptor antagonists
Antiemetics, serotonin 5-HT3-receptor antagonists
Antifungal drugs
Antihistamines (H1-receptor antagonists)
Antimotility drugs
Antimuscarinics, bronchodilators
Antimuscarinics, cardiovascular and gastrointestinal uses
Antimuscarinics, genitourinary uses
Antipsychotics, first-generation (typical)
Antipsychotics, second-generation (atypical)
Antiviral drugs
Antiplatelet drugs, ADP-receptor antagonists
Antiplatelet drugs, aspirin
Azathioprine
β-blockers
β2-agonists
Benzodiazepines
Bisphosphonates
Calcium and vitamin D
Calcium channel blockers
Carbamazepine
Cephalosporins and carbapenems
Chloramphenicol
Corticosteroids (glucocorticoids), inhaled
Corticosteroids (glucocorticoids), systemic
Corticosteroids (glucocorticoids), topical
Digoxin
Dipeptidylpeptidase-4 inhibitors
Direct oral anticoagulants
Diuretics, loop
Diuretics, thiazide and thiazide-like
Dopaminergic drugs for Parkinson’s disease
Emollients
Fibrinolytic drugs
Gabapentin and pregabalin
H2-receptor antagonists
Heparins and fondaparinux
Insulin
Iron
Lamotrigine
Laxatives, osmotic
Laxatives, stimulant
Leukotriene receptor antagonists
Levetiracetam
Lidocaine
Macrolides
Metformin
Methotrexate
Metronidazole
Naloxone
Nicotine replacement and related drugs
Nitrates
Nitrofurantoin
Non-steroidal antiinflammatory drugs
Ocular lubricants (artificial tears)
Oestrogens and progestogens
Opioids, strong
Opioids, weak/moderate
Oxygen
Paracetamol
Penicillins
Penicillins, antipseudomonal
Penicillins, broad-spectrum
Penicillins, penicillinase-resistant
Phosphodiesterase (type 5) inhibitors
Prostaglandin analogue eye drops
Proton pump inhibitors
Quinine
Quinolones
Serotonin 5-HT1-receptor agonists
Sex hormone antagonists for breast cancer
Statins
Sulphonylureas
Tetracyclines
Thyroid hormones
Trimethoprim
Valproate (valproic acid)
Vancomycin
Vitamins
Warfarin
Z-drugs
Fluids
Colloids (plasma substitutes)
Compound sodium lactate (Hartmann’s solution)
Glucose (dextrose)
Potassium chloride
Sodium chloride
Self-assessment and knowledge integration
100 single best-answer questions
Answers and explanations
- Edition: 3
- Published: December 13, 2022
- Language: English
AH
Andrew W. Hitchings
Affiliations and expertise
Reader in Clinical Pharmacology, St George’s, University of London, Honorary Consultant in Neurointensive Care, St George’s University Hospitals NHS Foundation Trust, London, UKDL
Dagan Lonsdale
Dagan Lonsdale, BSc(Hons) MBBS MRCP FHEA, Honorary Senior Lecturer, St George’s, University of London; Specialty Registrar in Clinical Pharmacology, General Medicine and Intensive Care Medicine, St George’s University Hospitals NHS Foundation Trust, London, UK
Affiliations and expertise
Honorary Senior Lecturer, St George’s, University of London; Specialty Registrar in Clinical Pharmacology, General Medicine and Intensive Care Medicine, St George’s University Hospitals NHS Foundation Trust, London, UKDB
Daniel Burrage
Daniel Burrage, BSc(Hons) MBBS MSc (Med Ed) MRCP FHEA , NIHR Doctoral Research Fellow, St George’s, University of London; Specialty Registrar in Clinical Pharmacology, General Medicine and Stroke Medicine, St George’s University Hospitals NHS Foundation Trust, London, UK
Affiliations and expertise
NIHR Doctoral Research Fellow, St George’s, University of London; Specialty Registrar in Clinical Pharmacology, General Medicine and Stroke Medicine, St George’s University Hospitals NHS Foundation Trust, London, UKEB
Emma Baker
Professor Emma Baker (PhD FRCP) is a clinical academic with roles in research, teaching and clinical medicine. At St George’s, University of London she is the head of the Clinical Pharmacology Unit, lead for prescribing education and assessment and chair of the Drugs and Therapeutics Committee. Current external roles include respiratory specialty group lead, (London South Comprehensive Local Research Network) and executive editor of the British Journal of Clinical Pharmacology.
In research, she gained her PhD from Manchester University in 1996. She subsequently moved to St George’s and developed a research programme in epithelial transport and respiratory infection, with external funding from bodies including the Wellcome Trust and Medical Research Council. Her research has developed from early work in molecular biology to development and implementation of investigator-led clinical trials.
In teaching, she was awarded a National Teaching Fellowship of the Higher Education Academy in 2003 and has received a St George’s undergraduate teaching prize in eight different years. She has co-authored a respiratory text book (Case-based respiratory medicine) and is currently leading her clinical pharmacology trainees in writing two new prescribing textbooks for publication in 2014.
In clinical practice, she has a specialist interest in chronic obstructive pulmonary disease and runs an outpatient service for patients with airways disease. She shares the inpatient care of respiratory patients with four colleagues and is on the on call rota for acute medical intaking.
Affiliations and expertise
Professor of Clinical Pharmacology, St George’s University of London; Honorary Consultant Physician, St George’s University Hospitals NHS Foundation Trust, London, UK.